What is Halozyme Therapeutics's investment proceeds?

Halozyme Therapeutics (HALO) reported investment proceeds of $9M in Q1 2026.

How has Halozyme Therapeutics's investment proceeds changed year-over-year?

Halozyme Therapeutics's investment proceeds decreased by 82.1% year-over-year, from $50.17M to $9M.

What is the long-term trend for Halozyme Therapeutics's investment proceeds?

Over 4 years (2021 to 2025), Halozyme Therapeutics's investment proceeds has grown at a 30.7% compound annual growth rate (CAGR), from $247.68M to $722.25M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Halozyme Therapeutics HALO Investment Proceeds

Investment Proceeds at other companies

BridgeBio PharmaBBIO

$10M—

Arrowhead ResearchARWR

$115.34M-2.4%

AlkermesALKS

$42.61M-62.5%

United TherapeuticsUTHR

$1.31B—

Krystal Biotech, Inc.KRYS

$103.6M+16.7%

ViatrisVTRS

——

Other financials

Income statement

See full

Revenue$376.7M+42.2%

Gross profit$297.5M+37.4%

Operating income$184.5M+30.4%

Net income$150.0M+27.1%

EPS (diluted)$1.22+31.2%

Balance sheet

See full

Cash & equivalents$312.0M+76.9%

Total debt$2.2B+41.7%

Total equity$219.6M-54.5%

Total assets$2.7B+21.7%

Cash flow

See full

Operating cash flow$180.1M+16.8%

CapEx$3.7M+294%

Free cash flow$176.3M+15.0%

Valuation

See full

Market cap$8.13B-2.9%

Enterprise value$10B+3.0%

P/E13.4×-3.8×

P/S5.4×-2.3×

Profitability

See full

Gross margin82.8%-0.7pp

Operating margin59.3%+9.0pp

Net margin47.9%+6.5pp

FCF margin44.3%-1.5pp

Returns & leverage

See full

Return on equity124.5%+12.7pp

Debt / equity9.9×+6.7×

Current ratio2.8×-5.6×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt.

The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Halozyme Therapeutics's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Halozyme Therapeutics's investment proceeds?: Halozyme Therapeutics (HALO) reported investment proceeds of $9M in Q1 2026.
How has Halozyme Therapeutics's investment proceeds changed year-over-year?: Halozyme Therapeutics's investment proceeds decreased by 82.1% year-over-year, from $50.17M to $9M.
What is the long-term trend for Halozyme Therapeutics's investment proceeds?: Over 4 years (2021 to 2025), Halozyme Therapeutics's investment proceeds has grown at a 30.7% compound annual growth rate (CAGR), from $247.68M to $722.25M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.